Francis Willard Sarena
General Counsel, PDL BIOPHARMA, INC.
Companies
- 89bio, Inc.Chief operating officer Aug 7, 2024 to now1
- Apexigen, Inc.President May 25, 2023 to Aug 25, 20232
- Apexigen, Inc.Chief operating officer Aug 8, 2022 to Aug 25, 20233
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- 89bio, Inc.0 shares4Oct 30, 2025
- Apexigen, Inc.0 shares5Aug 23, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Oct 30, 2025U 75,310 shares of 89bio, Inc.4
- Aug 5, 2025Shares withheld for tax 2,979 shares at $9.69 of 89bio, Inc.6
- Aug 1, 2025Shares withheld for tax 3,206 shares at $9.16 of 89bio, Inc.6
- Feb 1, 2025Granted 53,750 shares of 89bio, Inc.7
- Aug 5, 2024Granted 25,000 shares of 89bio, Inc.8
- Aug 23, 2023Returned to company 124,296 shares of Apexigen, Inc.5
- Aug 23, 2023Shares withheld for tax 31,123 shares at $0.39 of Apexigen, Inc.5
- Jun 15, 2023Shares withheld for tax 6,917 shares at $0.49 of Apexigen, Inc.9
- May 23, 2023Shares withheld for tax 20,748 shares at $0.40 of Apexigen, Inc.10
- May 23, 2023Granted 150,000 shares of Apexigen, Inc.10
- Dec 15, 2022Shares withheld for tax 6,916 shares at $1.06 of Apexigen, Inc.11
- Oct 7, 2022Granted 40,000 shares of Apexigen, Inc.12
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGAR89bio, Inc., Chief operating officer
- 2SEC EDGARApexigen, Inc., President
- 3
- 4
- 5
- 6SEC EDGARForm 4 filed Aug 5, 2025
- 7SEC EDGARForm 4 filed Feb 4, 2025
- 8SEC EDGARForm 4 filed Aug 7, 2024
- 9SEC EDGARForm 4 filed Jun 23, 2023
- 10SEC EDGARForm 4 filed May 25, 2023
- 11SEC EDGARForm 4 filed Dec 19, 2022
- 12SEC EDGARForm 4 filed Oct 11, 2022